Preclinical Modeling Services
17 services found
Manufactured by:Sartorius AG based inGoettingen, GERMANY
A more seamless transition into the clinic. Complex biopharmaceuticals and advanced therapies can present challenges during preclinical development. When implementing an albumin-based solution, Albumedix can help avoid unnecessary complications in your preclinical testing by creating species-specific recombinant albumins to suit your preclinical ...
by:Genome Biologics based inFrankfurt am Main, GERMANY
Using our platform, we have uncovered novel therapeutic RNAi approaches that aid heart cell regeneration and proliferation. Patents, publications in progress; compounds validated in preclinical ...
Manufactured by:TissUse GmbH based inBerlin, GERMANY
TissUse offers high-value service contracts to create custom solutions for safety evaluation of drugs, cosmetics and chemicals, and pre-clinical human disease modelling. Any new chip design serving customer needs with a specific organ arrangement can be prototyped and produced at short notice due to a proprietary rapid prototyping procedure established at TissUse. The versatile TissUse approach ...
Manufactured by:Creative Biogene based inShirley, NEW YORK (USA)
Creative Biogene has long-standing experience in conducting preclinical zebrafish model studies of cardiovascular disease. We offer consultancy and preclinical zebrafish models of cardiovascular disease including hypertension, arrhythmia, heart failure and atherosclerosis, etc. Similar to other animal models, ...
Distributed by:Avicanna Inc. based inToronto, ONTARIO (CANADA)
Advanced scientific platform for drug delivery, pre-clinical and clinical development. Team of 10+ scientists, deploying optimized proprietary methodologies in extraction, formulation development, analytical testing, pre-clinical models, and clinical development. Comprehensive IP portfolio across all platforms that has led to the development of 20+ proprietary commercial products. R&D ...
Manufactured by:Galera Therapeutics, Inc. based inMalvern, PENNSYLVANIA (USA)
Harnessing the Anticancer Power of Hydrogen Peroxide: As cancer cells are more susceptible than normal cells to increased levels of hydrogen peroxide, we believe the conversion of radiation-generated superoxide to hydrogen peroxide by our selective dismutase mimetics can improve outcomes for patients who receive radiation ...
Manufactured by:Pega Medical Inc. based inLaval, QUEBEC (CANADA)
If you need to know whether your product meets the national and international regulatory requirements for safety and effectiveness, or how it compares to the competition's products, Pega Medical Services can perform in-vitro biomechanical evaluation of your new product to verify its structural integrity and function, as well as recommend possible modifications. Our technical staff possesses vast ...
Manufactured by:Neurodigitech, LLC based inEncinitas, CALIFORNIA (USA)
In particular, NDT is dedicated to custom-designed neuropathological assessments for the neurodegenerative diseases, such as Alzheimer's, Parkinson's, ALS, and brain insults (strokes and brain tumors) and Human neural stem cell and small molecule biomarker programs for preclinical studies of animal models upon request. NDT helps our clients develop the most time- ...
Manufactured by:SCIREQ - an emka TECHNOLOGIES Company based inMontreal, QUEBEC (CANADA)
Surgical skills are needed for all our implanted telemetry and for some in vitro isolated organs ...
by:Vaiomer based inLabège, FRANCE
Translational research: from animal models to treating patients. Animal models are essential in understanding the role of microbiomes in health and diseases whether the endpoint is to improve human or animal health. In basic research and preclinical studies, animal models such as mice, rats, hamsters or others, enable ...
Manufactured by:MODAG GmbH based inWendelsheim, GERMANY
Certain proteins including α-synuclein can form disease-specific fibrillar amyloid aggregates. The misfolding/ aggregation pathway resulting in amyloid fibrils involves characteristic oligomer species which have been shown to be the most relevant toxic protein species. These pathological oligomers exhibit structural epitopes that are not found in physiologically folded proteins or ...
by:elminda Ltd. based inHerzliya, ISRAEL
CNS drugs exhibit the lowest approval success rates due to multiple challenges such as lack of efficacy in early and advanced stages of development, Poor target selection / engagement, poor translation from pre-clinical models and disease heterogeneity. BNA may contribute in CNS research and drug development by adding new objective endpoints, assisting in understanding drug mechanism, identifying ...
Manufactured by:Kiadis Pharma NV based inAmsterdam, NETHERLANDS
Innovative antibody-based molecular concepts. New treatments for cancer that leverage our own immune system to attack and destroy cancer cells can provide long-term and durable therapeutic responses in patients suffering from life-threatening malignancies. These benefits for patients have been driven by recently developed therapeutic antibodies binding with high specificity to drug targets on ...
Manufactured by:InnoSer Belgie NV based inDiepenbeek, BELGIUM
We offer multi-validation solutions for preclinical targets across numerous therapeutic fields. ...
by:PharmaBiome AG based inSchlieren, SWITZERLAND
Leading-edge therapies that leverage the microbiome promise to address a range of serious diseases that currently don’t have adequate solutions. Microbiome-based therapies are de-risked thanks to the established proof-of-concept with fecal matter transplant ...
by:Almac Group based inCraigavon, UNITED KINGDOM
Almac Diagnostic Services can also help Biopharma clients validate reliable Pharmacodynamic (PD) Biomarker assays that can help provide invaluable guidance within their drug development programmes. Almac also has extensive experience in the discovery of clinically applicable biomarkers, through our own range of Almac proprietary assays (DDIR, Prostate Dx, ColDx, Angio, and EMT) and through ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Prostate cancer is the most common type of cancer (aside from skin) in American men with 13 out of every 100 being diagnosed with the disease during their lifetime.1,2Prostate-specific membrane antigen (PSMA) is a transmembrane protein that is expressed in high levels in prostate cancer cells. Due to its location on the cell surface, PSMA is a popular target for imaging to identify the presence ...